Skip to content

Trial Summary

The purpose of this study is to evaluate the safety, tolerability, and preliminary activity of SQ3370 in patients with advanced solid tumors.



ACTRN/NCT /ethics:


Scientific title:

A Multicenter Phase 1, Open-Label Study of SQ3370 in Patients with Advanced Solid Tumors

Sponsor / Cooperative group:

Shasqi, Inc.

Trial & Patient Characteristics

Cancer TypeAll cancers
Trial TypeTreatment
PhasePhase I
Age Range18 years and older
Tumour Stream -
Cancer StageLocally Recurrent or Locally Advanced
Anticipated Start Date2020-08-01
Anticipated End Date2026-07-09

Participating Hospitals

HospitalCancer Research SA
Clinical Trial CoordinatorKelly Mead
Phone08 8359 2565
Principal InvestigatorDr Vineet Kwatra
Recruitment StatusRecruiting